Glycanostics
Top Slovak biotech company with ground-breaking solution for early cancer diagnosis
SK
CompaniesEquityFunded
Equity
This opportunity has no news yet
€1,000,000
Target amount
43
Investors
25 - 50% p.a.
Required return
You cannot invest in this opportunity at the moment